In addition to the increase of GLP-1 levels, one study has shown that linagliptin, as a DPP-4 inhibitor, exhibits a neuroprotective effect on Aβ-induced neurotoxicity associated with AD[27]. The gene discussed is DPP4; the disease is Alzheimer disease.